## Background: We performed a population-based study to determine the incidence and patterns of second malignant neoplasia (smn) in early glottic carcinoma. ## Methods: All patients diagnosed with tis-t1 glottic carcinoma in the southwest of the netherlands between 1982 and 1993 (359) were includ
Second primary respiratory tract malignancies in glottic carcinoma
β Scribed by Derrick J. H. Wagenfeld; Andrew R. Harwood; Douglas P. Bryce; A. W. Peter Van Nostrand; Gerrit Deboer
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 394 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Primary fallopian tube cancer (PFTC) is a rare disease, and its aetiological factors are poorly understood. Studies on PFTC in the setting of 2nd primary malignant neoplasms can provide clues on aetiology and also define the possible side effects of different treatment modalities for PF
Two adenoid cystic carcinomas, one of the nasal cavity, the other a bronchial tumor, were cytogenetically analyzed. The former had a t(6;9)(q21-22;pl3-21) as the sole karyotypic abnormality. The latter had two related abnormal clones, resulting in the mosaic karyotype 46,XY,t(9; I7)(p I 3;p I 3)/46,
## Abstract ## Background. We aimed to identify patterns and predictors of second primary malignancy (SPM) of the aerodigestive tract (SPMADT) in patients with squamous cell carcinoma of the oral cavity (SCCOC) and larynx (SCCL). ## Methods. One thousand two hundred fiftyβseven patients from two
Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c
## Abstract Survival from soft tissue tumors (STTs) has been improved because of the successful treatment. One of the late sequelae in STT survivors is the development of a second malignancy. The present study aimed at quantifying risks for second malignancies in patients with STTs, and risks for s